Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 30, 2026
Procter & Gamble (PG) Delivers Mixed Q4 Results as Shares Decline 3-4%

Procter & Gamble (PG) Delivers Mixed Q4 Results as Shares Decline 3-4%

Key Takeaways

  • Revenue fell short of expectations: Q4 FY2026 net sales reached $21.2 billion, up 2% year-over-year but missing the consensus estimate of approximately $21.38 billion.
  • Core EPS narrowly beat estimates: Adjusted core earnings per share (EPS) came in at $1.43, edging past the analyst consensus of $1.42, though declining 3% from $1.48 in the prior-year quarter.
  • Organic sales were flat: Organic sales growth — a key metric that strips out currency fluctuations, acquisitions, and divestitures — registered 0%, with volume, pricing, and mix all neutral in the quarter.
  • Margins under pressure: Core operating margin contracted 130 basis points year-over-year, marking the third consecutive quarter of margin compression, driven by higher SG&A (selling, general and administrative) costs and commodity inflation.
  • FY2027 guidance disappointed: Management issued fiscal 2027 core EPS guidance of $6.89 to $7.11, with a midpoint of $7.00, slightly below consensus, while projecting total sales growth of just 1% to 3%.
  • Shares declined sharply: PG stock fell approximately 3% to 4% in intraday trading following the release, reflecting investor concern over the soft revenue print and cautious forward outlook.

Earnings Context and Why It Matters

Procter & Gamble’s fourth-quarter fiscal 2026 results, reported on July 29, 2026, provide a useful window into the consumer staples sector during a period of ongoing macroeconomic pressure. As one of the largest consumer packaged goods companies—with well-known brands such as Tide, Pampers, Gillette, and Crest—PG serves as a useful indicator of household spending and broader consumer trends. This report is particularly relevant given persistent inflation, elevated commodity costs partly linked to geopolitical tensions, and more price-sensitive consumers who are shifting toward value options in some categories. With full-year organic sales growth slowing to 1% (down from 2% in FY2025 and 4% in FY2024), investors are watching closely to see whether PG can restore volume growth while maintaining profitability.

Reported Results

For the fourth quarter of fiscal 2026 ended June 30, 2026, Procter & Gamble reported net sales of $21.2 billion, a 2% increase from $20.9 billion in the prior-year period. The top line nonetheless came in below the analyst consensus of approximately $21.38 billion. Foreign exchange added about one percentage point to growth, while volume, pricing, and mix were neutral overall, leaving organic sales flat year-over-year.

GAAP diluted net EPS declined 15% to $1.26, affected by lower gross margins and higher SG&A expenses. Core EPS, which excludes certain one-time items, fell 3% to $1.43 but still edged past the consensus of $1.42. On a currency-neutral basis, core EPS declined 5% from the prior year. Net earnings totaled $3.04 billion, down 16% from $3.62 billion a year earlier.

Segment results were mixed. Beauty delivered 4% organic sales growth, supported by mid-single-digit gains in hair care and skin and personal care. Grooming and Fabric & Home Care were flat organically, Health Care declined 1%, and Baby, Feminine & Family Care posted a 2% organic sales drop as both volume and pricing weakened. I also checked this using Tickeron’s AI Screener to see how PG stacks up against peers in the sector.

For the full fiscal year 2026, PG reported net sales of $87.0 billion (up 3%) and core EPS of $6.89 (up 1%). Operating cash flow reached $19.6 billion, and the company returned more than $15 billion to shareholders through $10.2 billion in dividends and $5.0 billion in share repurchases. The April 2026 dividend increase marked the 70th consecutive year of dividend growth.

Market Reaction and Investor Sentiment

Investors reacted negatively to the results, with PG shares declining roughly 3% to 4% in Wednesday trading. Although the small core EPS beat provided a modest positive, the revenue miss and cautious fiscal 2027 outlook weighed more heavily on sentiment. Management highlighted roughly $1 billion in after-tax headwinds from higher raw material, energy, and transportation costs, partly tied to Middle East developments and oil prices near $90 per barrel. With organic sales stalled and three of five segments showing flat or negative growth, the market focused on the durability of top-line momentum and margin resilience. From what I see, the reaction underscores that investors are prioritizing sustained revenue growth over a one-penny EPS beat in the current environment.

Forward Outlook and Key Factors to Monitor

Looking ahead to fiscal 2027, Procter & Gamble expects organic sales growth of 1% to 3% and core EPS between $6.89 and $7.11, implying flat to 3% growth versus fiscal 2026. Management noted that the first quarter is likely to be the most difficult, with EPS expected to decline at least 5% year-over-year before conditions improve later in the year.

Key variables include the path of commodity costs, especially crude oil, which affects raw materials, energy, and transportation. The company is budgeting for approximately $1 billion in after-tax commodity headwinds, or about $0.56 per share—an 8% drag on core EPS growth. Consumer behavior will also matter, particularly as lower-income households continue to seek value and private-label options. The Beauty segment has held up well, but softness in Grooming, Health Care, and Family Care deserves attention.

Productivity efforts remain central. PG achieved 340 basis points of productivity savings in fiscal 2026 and plans to fund reinvestments through further efficiency gains. E-commerce, which grew 6% and now accounts for 20% of sales, is another area of focus. I’m watching this closely as digital channels continue to evolve. Investors should track quarterly organic sales trends, segment volume performance, and margin trends throughout the year.

Using Tickeron’s AI Tools in My Research

When evaluating earnings reports like this one, I find it helpful to run quick comparisons with Tickeron’s AI Screener. The tool lets me filter stocks by industry, market cap, technical signals, and other criteria to see how PG and similar names are performing relative to peers. It saves time and surfaces ideas I might otherwise miss during earnings season.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PG

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


PG in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 30, 2026

PG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where PG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 48 cases where PG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for PG moved above the 200-day moving average on July 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PG advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PG as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PG moved below its 50-day moving average on August 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PG crossed bearishly below the 50-day moving average on August 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.305) is normal, around the industry mean (23.642). P/E Ratio (21.855) is within average values for comparable stocks, (56.718). Projected Growth (PEG Ratio) (4.146) is also within normal values, averaging (2.919). Dividend Yield (0.030) settles around the average of (0.034) among similar stocks. P/S Ratio (4.027) is also within normal values, averaging (2.707).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.32B. The market cap for tickers in the group ranges from 81.32K to 336.3B. PG holds the highest valuation in this group at 336.3B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -5%. EL experienced the highest price growth at 18%, while YSG experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 56
SMR Rating: 70
Profit Risk Rating: 91
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
PG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of branded consumer packaged goods

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
One Procter and Gamble Plaza
Phone
+1 513 983-1100
Employees
107000
Web
https://www.pginvestor.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.